Internalization with high targeting potential of mouse monoclonal antibody ONS-M21 recognizing human malignant glioma antigen

Cancer Letters

Volumn 127, Issue 1-2, 1998, Pages 171-176

  Shimizu, Keiji ^a   Park, Kae Chang ^a   Tamura, Kazuyoshi ^a   Kishima, Haruhiko ^a   Kawata, Hiromitsu ^b   Yoshimura, Yasushi ^b   Sekimori, Yasuo ^b   Miyao, Yasuyoshi ^a   Hayakawa, Toru ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Chugai Pharmaceutical Company Limited   (Japan)

Author keywords

Imunotoxin; Internalization; Malignant glioma; Monoclonal antibody; Ricin A

Indexed keywords

ANTIBODY CONJUGATE; IMMUNOTOXIN; IODINE 125; MONOCLONAL ANTIBODY; RICIN A; TUMOR ANTIGEN;

ARTICLE; ASTROCYTOMA; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DISULFIDE BOND; DNA SYNTHESIS; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; INTERNALIZATION; ISOTOPE LABELING; MEDULLOBLASTOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ASTROCYTOMA; CELL SURVIVAL; EVALUATION STUDIES; GLIOMA; HUMANS; IMMUNOTOXINS; MEDULLOBLASTOMA; MICE; RICIN; TUMOR CELLS, CULTURED;

EID: 0032523986     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00030-5     Document Type: Article

References (30)

1. Allan P.M., Garson J.A., Harper E.I., Asser U., Coakham H.B., Brownell B., Kemshead J.T. Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int. J. Cancer. 31:1983;591-598.
2. D.C. Blakey, E.J. Wawrzynczak, P.M. Wallance, P.E. Thorpe, Antibody-toxin conjugates: a perspective, in: H. Waldman (Ed.), Monoclonal Antibody Therapy, Progress in Allerge, Vol. 45, Karger, Basel, 1988, p. 50.
3. Cumber A.J., Forrester J.A., Foxwell B.M.J., Ross W.C.J., Thorpe P.E. Preparation of antibody-toxin conjugates. Methods Enzymol. 112:1985;207-225.
4. Farwell J.R., Dohrmonn G.J., Flanney J.T. Medulloblastoma in childhood: an epidemiological study. J. Neurosurg. 61:1984;657-664.
5. Fine H.A., Dear K.B., Loeffler J.S., Black P.M., Canellos G.P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 71:1993;2585-2597.
6. Forrester J.A., McIntosh D.P., Cumber A.J., Parnell G.D., Ross W.C.J. Delivery of ricin and abrin A chains to human carcinoma cells in culture following linkage to monoclonal antibody LICR-LOND-Fib75. Cancer Drug Deliv. 1:1984;283-292.
7. y specific antibody with potent anti-tumor activity is internalized and degraded in lysosomes. Am. J. Pathol. 39:1993;554-559.
8. Gibson F.M., Kemshead J.T. A monoclonal antibody (FMG25) that can differentiate neuroblastoma from other small round-cell tumours of childhood. Int. J. Cancer. 39:1987;554-559.
9. Goldmacher V.S., Scott C.F., Lambert J.M., McIntyre G.D., Blatter W.A., Collinson A.R., Stewart J.K., Chong L.D., Cook S., Slayter H.S., Beaumont E., Watkins S. Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosis. J. Cell Physiol. 141:1989;222-234.
10. Hamilton T.C., Ozols R.F., Longo D.L. Biologic therapy for the treatment of malignant common epithelial tumors of the ovary. Cancer. 60:1987;2054-2063.
11. Hershatter B.W., Halperin E.C., Cox E.B. Medulloblastoma: the Duke University Medical Center experience. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;1771-1777.
12. Herter A.A., Frankel A.E. Immunotoxins: a clinical review of their use in the treatment of malignancies. J. Clin. Oncol. 7:1989;1932-1942.
13. Jennings M.T., Jennings V.D.L., Asadourian L.L.H., Rosenblum M., Albio A.P., Cairncross J.G., Old L.J. Five novel cell surface antigens of CNS neoplasms. J. Neurol. Sci. 89:1989;63-78.
14. Martell L.A., Agrawal A., Ross D.A., Muraszko K.M. Efficiency of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res. 53:1993;1348-1353.
15. Moriuchi S., Shimizu K., Miyao Y., Hayakawa T. Characterization of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastoma and gliomas. Br. J. Cancer. 68:1993;831-837.
16. Ohtomo T., Tsuchiya M., Sato K., Shimizu K., Moriuchi S., Miyao Y., Akiyama T., Akamatu K., Hayakawa T., Ohsugi Y. Humanization of mouse ONS-M21 antibody with the aid of hybrid variable regions. Mol. Immunol. 32:1995;407-416.
17. Preijers H., Tax W., de Witte T., Jansen A., Heijden H., Vidal H. Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins. Br. J. Haematol. 70:1988;289-294.
18. Ramakrishnan S., Olson T.A., Bautch V.L., Mohanraj D. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo. Cancer Res. 56:1996;1324-1330.
19. Recht D.L., Raso V., Davis R., Salmonsen R. Immunotoxin sensitivity of Chinese hamster ovary cells expressing human transferrin receptors with differing internalization rates. Cancer Immunol. Immunother. 42:1996;357-361.
20. Rosenblum M.G., Cheung L., Kim S.K., Mujoo K., Donato N.J., Murry J.L. Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to resistant cells. Cancer Immunol. Immunother. 42:1996;115-121.
21. Rothenberger S., Iacopetta B.J., Kuhn L.C. Endocytosis of the transferrin receptor. Cell. 49:1987;423-431.
22. Sandberg-Wollheim M., Malmstrom P., Stromblad L.G., Anderson H., Borgstrom S., Brun A., Cronqvist S., Hougrrad K., Salford L.G. A randomized study of chemotherapy with procarbazine, vincristine with and without radiation therapy for astrocytoma grade 3 and/or 4. Cancer. 68:1991;22-29.
23. Suzuki S., Inoue K., Hongoh A., Hashimoto Y., Yamazoe Y. Modulation of doxorubicin resistance in a doxorubicin-resistant human leukemia cell by an immunoliposome targeting transferring receptor. Br. J. Cancer. 76:1997;83-89.
24. Takahashi H., Belser P.H., Atkinson B.F., Sela B.A., Ross A.H., Biegel J., Emanuel B., Sutton L., Koprowski H., Herlyn D. Monoclonal antibody-dependent, cell-mediated cytotoxicity against human malignant gliomas. Neurosurgery. 27:1990;97-102.
25. Vaickus L., Foon K.A. Overview of monoclonal antibodies in the diagnosis and therapy of cancer. Cancer Invest. 9:1991;195-209.
26. Walker M.D., Green S.B., Byar D.F., Alexander E. Jr., Batzorf U., Brooks W.H., Hunt W.E., MacCarty C.S., Mahaley M.S., Mealey J. Jr., Owens G., Ransohoff J., Robertson J.T., Shapiro W.R., Smith K.R., Wilson G.R., Strike T.A. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl. J. Med. 303:1980;1323-1329.
27. Wallner K.E., Galicich J.H., Krol G., Arbit E., Malkin M.G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1405-1409.
28. Wawrzynczak E.J., Derbyshire E.J., Henry R.V., Parnell G.D., Smith A., Waibel R., Stahel R.A. Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognizing a human small cell lung cancer antigen. Br. J. Cancer. 62:1990;410-414.
29. Wikstrand C.J., Mclendon R.E., Bullard D.E., Fredman P., Svennerholm L., Bigner D.D. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies. Cancer Res. 46:1986;5933-5940.
30. Yamada M., Shimizu K., Tamura K., Okamoto Y., Matsui Y., Moriuchi S., Park K.C., Mabuchi E., Yamamoto K., Hayakawa T., Mogami H. Establishment and biological characterization of human medulloblastoma cell lines. Brain Nerve. 41:1989;695-702.